The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.75
Bid: 16.50
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.03%)
Open: 16.75
High: 16.75
Low: 16.75
Prev. Close: 16.75
IHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corrected rPAP Driver Unit Granted CE mark notice

17 Oct 2017 09:15

RNS Number : 7994T
Inspiration Healthcare Group PLC
17 October 2017
 

17 October 2017

 

 

The following statement has been amended in the "Neonatal Resuscitation Driver Granted CE mark" announcement issued at 7am on 17 October 2017 by Inspiration Healthcare Group PLC under RNS Number: 7473T

 

" rPAPä" Has been amended to "rPAP" 

All other information remains unchanged. The full amended text appears below.

 

 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

 

rPAP Neonatal Resuscitation Driver Unit Granted CE mark 

 

 

Inspiration Healthcare Group plc (AIM: IHC), the global supplier of medical technology for critical care, operating theatre and other medical applications, is delighted to announce that the rPAP Driver unit which is an integral part of the Inspire rPAP neonatal resuscitation system has been granted a CE mark* and can now be sold throughout the EU and certain other territories around the world.

 

The unit, which regulates gas flow entering into a resuscitation device, has been entirely designed by Inspiration Healthcare and complements the first of its own designed medical devices sold by the company, the rPAP Generator. The rPAP Driver and rPAP Generator combine to form the Inspire rPAP system.

 

The Drivers are re-usable which presents significant cost benefits to users without stretching limited capital equipment budgets. They are compact, lightweight and portable and when coupled with the rPAP Generator, the system reduces the effort needed to breathe during the first few minutes of life of a baby that needs resuscitation due to difficulties at the time of birth. The system is being used by a number of hospitals in Scandinavia as part of a multicentre clinical trial.

 

Commenting today, Neil Campbell Inspiration Healthcare's Chief Executive Officer said: "We are delighted to get this approval which means we can begin to distribute the products to the many customers who have already indicated their interest.

 

The Inspire rPAP combines many innovative features into one portable, easy to use system and is designed to work with our "LifeStart" neonatal resuscitation platform which is to be used in a wide range of innovative clinical procedures being adopted in neonatal units such as optimal cord clamping."

 

* CE marking is a mandatory conformity marking for certain products sold within the European Economic Area (EEA).

 

 

Enquiries:

 

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Mike Briant, Chief Financial Officer

Tel: 01455 840555

 

Nominated Adviser & Broker

Cenkos Securities plc

Mark Connelly, Bobbie Hilliam (NOMAD)

 

Michael Johnson (Sales)

Tel: 0207 397 8900

 

Cadogan PR

Alex Walters

Tel: 07771 713608

 

 

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) is a global supplier of medical technology for critical care, operating theatre and other medical applications. The Company provides high quality innovative products to patients and caregivers around the world that help to improve patient outcomes and efficiencies of healthcare organisations with patient focused customer service and technical support.

 

The Company's own brand of critical care solutions span non-invasive respiratory management, thermoregulation and diagnostics, and patient warming for newborns through to adults in intensive care and the operating theatre, whilst the distribution business supplies solutions to support specialised surgical procedures and infusion therapies.

 

Present in over 50 countries worldwide, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving the quality of life of patients, working in close collaboration with key opinion leaders and stakeholders in the clinical and medical community across the globe.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGMMMGRNNGNZG
Date   Source Headline
5th Sep 20197:00 amRNSProposed Acquisition of Vio Holdings and Placing
15th Aug 20197:00 amRNSTrading Update
27th Jun 20191:16 pmRNSResult of AGM
27th Jun 20197:00 amRNSAGM Statement
28th May 20197:00 amRNSUpdate regarding NPXe plc
23rd May 20197:00 amRNSNotice of AGM
30th Apr 20197:00 amRNSPreliminary Results
23rd Apr 20197:00 amRNSWinning of Queen's Award for Enterprise
20th Mar 20197:00 amRNSCertification received to the new MDSAP
14th Mar 20197:00 amRNSLargest Ever Patient Warming System Order
22nd Feb 20197:00 amRNSTrading Update and Notice of Results
11th Feb 201911:01 amRNSPrice Monitoring Extension
25th Jan 20197:00 amRNSGrowth & Innovation Forum 2019
18th Dec 20187:00 amRNSLicensing agreement with US University
7th Dec 20187:00 amRNSStatement re potential IPO of NeuroproteXeon
8th Nov 20187:00 amRNSGrant of Options
2nd Oct 20187:00 amRNSInterim Results
30th Aug 20187:00 amRNSInvestor Evening - 4 October 2018
24th Aug 20187:00 amRNSTrading Update and Notice of Results
3rd Jul 20187:00 amRNSRenewal of Tecotherm and Micrel Agreements
15th Jun 201812:30 pmRNSResult of AGM
15th Jun 20187:00 amRNSAGM Statement
7th Jun 20187:00 amRNSPotential IPO of NeuroproteXeon Limited
18th May 201811:59 amRNSPosting of Annual Report and Notice of AGM
9th May 20183:15 pmRNSNeuroproteXeon and Linde Distribution Partnership
24th Apr 20187:00 amRNSPreliminary Results
21st Feb 20187:00 amRNSTrading Update
18th Jan 20187:00 amRNSCFM unit granted CE mark and Neotech Agreement.
9th Jan 20187:00 amRNSAppointment of Head of Marketing
14th Nov 20177:00 amRNSEnhanced LifeStart launched at MEDICA
9th Nov 20177:00 amRNSGrant of Options
17th Oct 20179:15 amRNSCorrected rPAP Driver Unit Granted CE mark notice
17th Oct 20177:00 amRNSNeonatal Resuscitation Driver Granted CE mark
3rd Oct 20177:00 amRNSNeuroproteXeon and Mallinckrodt licence agreement
26th Sep 20177:00 amRNSInterim Results
11th Sep 20177:00 amRNSTR1 Notification of Major Interest in Shares
31st Aug 20177:00 amRNSOperational Appointments
25th Aug 20177:00 amRNSTrading Update and Notice of Results
17th Aug 20177:00 amRNSCapital Reduction
14th Aug 20177:00 amRNSInvestors Open Day
31st Jul 20172:45 pmRNSCapital Reduction
30th Jun 201712:01 pmRNSResult of AGM
30th Jun 20177:00 amRNSAGM Statement
19th May 20177:00 amRNSPosting of Annual Report and Notice of AGM
3rd May 20177:00 amRNSPreliminary Results
4th Apr 20174:25 pmRNSNotice of Results
4th Apr 20172:38 pmRNSHolding(s) in Company
6th Feb 20177:00 amRNSNew Corporate Office & Change of Registered Office
5th Dec 20161:05 pmRNSRevised Notification of Major Interest In Shares
28th Nov 201610:50 amRNSTR1 Notification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.